DIGP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DIGP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Hypha Labs's average Accounts Receivable for the three months ended in Dec. 2023 was $0.00 Mil. Hypha Labs's Revenue for the three months ended in Dec. 2023 was $0.00 Mil.
The historical rank and industry rank for Hypha Labs's Days Sales Outstanding or its related term are showing as below:
During the past 13 years, Hypha Labs's highest Days Sales Outstanding was 1471.41. The lowest was 23.17. And the median was 31.58.
Hypha Labs's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).
The historical data trend for Hypha Labs's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypha Labs Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | 24.81 | 29.85 | 33.31 | - | - |
Hypha Labs Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Sales Outstanding | Get a 7-Day Free Trial | - | - | - | - | - |
For the Diagnostics & Research subindustry, Hypha Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Hypha Labs's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Hypha Labs's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as
Days Sales Outstanding (A: Sep. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Sep. 2022 ) | + | Accounts Receivable (A: Sep. 2023 )) | / | count ) | / | Revenue (A: Sep. 2023 ) | * | Days in Period |
= | ( (0.335 | + | 0) | / | 1 ) | / | 0 | * | 365 |
= | 0.335 | / | 0 | * | 365 | ||||
= | N/A |
Hypha Labs's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding (Q: Dec. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Sep. 2023 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) | / | Revenue (A: Dec. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 / 4 |
= | 0 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypha Labs (OTCPK:DIGP) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Hypha Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
A Stone Douglass | director | 10200 WILLOW CREEK ROAD, SAN DIEGO CA 92131 |
Edmond Defrank | director | 19360 RINALDI STREET, #448, NORTHRIDGE CA 91326 |
Kyle Remenda | officer: Chief Executive Officer | 111-2532 SHORELINE DRIVE, LAKE COUNTRY A1 V4V2R6 |
Dennis Hartmann | director | 1600 CAMDEN AVENUE, NO. 103, LOS ANGELES CA 90025 |
Bruce I Raben | director | 430 VICTORIA TERRACE, RIDGEFIELD NJ 7657 |
Cindy Sue Orser | director | 4507 APPLE WAY, BOULDER CO 80301 |
Alfredo Axtmayer | director | 287 PAYNE DRIVE, CHESHIRE CT 06410 |
Joseph J Bianco | director | 611 BROADWAY,, SUITE 307, NEW YORK NY 10012 |
Todd A Peterson | officer: Chief Financial Officer | 3608 MALLARDWOOD DRIVE, LAS VEGAS NV 89129 |
Joe D Tanner | director | 28720 ROADSIDE DRIVE, SUITE 128, AGOURA HILLS CA 91301 |
Raw Alternative, Llc | 10 percent owner | 16030 VENTURA BLVD. SUITE 380, ENCINO CA 91436 |
Todd Denkin | director, officer: President | C/O PHOTOTRON, INC., 20259 VENTURA BLVD., WOODLAND HILLS CA 91364 |
Barbee Denny Barbee | 10 percent owner | 3105 EAST CENTRAL, #114, WICHITA KS 67214 |
Eric Stoppenhagen | director, 10 percent owner, officer: CFO | 8908 SPLITARROW DRIVE, AUSTIN TX 78717 |
From GuruFocus
By Marketwired Marketwired • 03-16-2020
By Value_Insider Value_Insider • 12-08-2022
By GuruFocusNews GuruFocusNews • 05-02-2022
By Marketwired Marketwired • 07-07-2021
By GuruFocusNews GuruFocusNews • 12-07-2021
By GuruFocusNews GuruFocusNews • 01-04-2022
By PRNewswire PRNewswire • 08-13-2019
By Marketwired Marketwired • 08-28-2019
By Marketwired Marketwired • 09-30-2019
By GuruFocusNews GuruFocusNews • 03-01-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.